DXCM Q4 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.0B+26.9% YoY

Gross Profit

$657M63.5% margin

Operating Income

$217M21.0% margin

Net Income

$256M24.8% margin

EPS (Diluted)

$0.62

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

$134M

Free Cash Flow

$81M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$6.3B

Total Liabilities

$4.2B

Stockholders' Equity

$2.1B

Cash & Equivalents

$566M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$815M	+26.9%
Gross Profit	$657M	$541M	+21.3%
Operating Income	$217M	$125M	+73.0%
Net Income	$256M	$92M	+179.2%

Geographic Segments

UNITED STATES

$769M74%

Non-US

$265M26%